Back
Rayliant Quantitative Dev Mkt Eq ETF Vs. Aligos Therapeutics Industry Stock Comparison
Buy
70
RAYD
Rayliant Quantitative Dev Mkt Eq ETF
Last Price:
33.33
Seasonality Move:
4.92%
Buy
72
ALGS
Aligos Therapeutics
Last Price:
33.28
Seasonality Move:
10.65%
Buy
70
Rayliant Quantitative Dev Mkt Eq ETF (RAYD)
is a Buy
Is Rayliant Quantitative Dev Mkt Eq ETF a Buy, Sell or Hold?
- The current Rayliant Quantitative Dev Mkt Eq ETF [RAYD] share price is $33.04. The Score for RAYD is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- RAYD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
- The current Aligos Therapeutics [ALGS] share price is $33.11. The Score for ALGS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RAYD Stock Price Chart
What is Rayliant Quantitative Dev Mkt Eq ETF's stock price today?
-
The Rayliant Quantitative Dev Mkt Eq ETF share price today is $33.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAYD is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $33.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
RAYD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 63.39 | Buy |
| Chaikin Money Flow: | -490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.26 - 33.1) | Buy |
| Bollinger Bands (100): | (29.5 - 32.24) | Buy |
ALGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.85 | Buy |
| Relative Strength Index (14 RSI): | 78.88 | Buy |
| Chaikin Money Flow: | -127407 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.12 - 28.52) | Buy |
| Bollinger Bands (100): | (7.57 - 20.11) | Buy |
RAYD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.17 | Sell |
| 20-day SMA: | 32.73 | Buy |
| 50-day SMA: | 31.96 | Buy |
| 200-day SMA: | 29.62 | Buy |
| 8-day EMA: | 33.05 | Sell |
| 20-day EMA: | 32.77 | Buy |
| 50-day EMA: | 32.05 | Buy |
| 200-day EMA: | 29.7 | Buy |
ALGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.4 | Buy |
| 20-day SMA: | 24.33 | Buy |
| 50-day SMA: | 15.25 | Buy |
| 200-day SMA: | 15.91 | Buy |
| 8-day EMA: | 29.74 | Buy |
| 20-day EMA: | 24.86 | Buy |
| 50-day EMA: | 18.75 | Buy |
| 200-day EMA: | 16.3 | Buy |
Rayliant Quantitative Dev Mkt Eq ETF Earnings Growth & RAYD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Rayliant Quantitative Dev Mkt Eq ETF Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aligos Therapeutics Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||